Rani Soenen
Gent, VLG, Belgium
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 17 publications
Population Pharmacokinetic-Pharmacodynamic Model for Secukinumab in Psoriasis Patients.
Journal: The Journal of investigative dermatology
Published: March 31, 2026
Dose Reduction of IL17 and IL23 Inhibitors in Psoriasis (BeNeBio study): An International, Pragmatic, Multicentre, Randomised, Controlled, Non-Inferiority Trial.
Journal: The Lancet regional health. Europe
Published: January 29, 2026
Building the foundations for an international patient-centred outcomes set for psoriasis: A scoping study.
Journal: Journal of the European Academy of Dermatology and Venereology : JEADV
Published: June 30, 2025
From reactive to predictive: Advancing biologic dosing in dermatology.
Journal: Journal of the European Academy of Dermatology and Venereology : JEADV
Published: June 29, 2025
Demographics, Disease Characteristics, and Time to Effective Treatment of Patients with Psoriasis in the Ghent PsoPlus Cohort of 2021.
Journal: Dermatology and therapy
Published: June 10, 2024
Best Practice for Therapeutic Drug Monitoring of Infliximab: Position Statement from the International Association of Therapeutic Drug Monitoring and Clinical Toxicology.
Journal: Therapeutic drug monitoring
Published: October 29, 2023
Exposure-response relationship of guselkumab and the potential of serum proteomics in identifying predictive biomarker candidates in psoriasis.
Journal: Journal of the European Academy of Dermatology and Venereology : JEADV
Published: September 29, 2023
Blocking interleukin-17 in psoriasis: Real-world experience from the PsoPlus cohort.
Journal: Journal of the European Academy of Dermatology and Venereology : JEADV
Published: June 17, 2022
Promising Tools to Facilitate the Implementation of TDM of Biologics in Clinical Practice.
Journal: Journal of clinical medicine
Published: May 03, 2022
Therapeutic drug monitoring in dermatology: the way towards dose optimization of secukinumab in chronic plaque psoriasis.
Journal: Clinical and experimental dermatology
Published: November 10, 2021
Effectiveness and tolerability of guselkumab in patients with psoriasis: A longitudinal Belgian retrospective multicenter study.
Journal: JAAD international
Published: August 19, 2021
Dermatologists on the medical need for therapeutic drug monitoring of biologics in psoriasis: results of a structured survey.
Journal: The Journal of dermatological treatment
Published: October 06, 2020
Last Updated: 09/26/2026